Zoliget

Zoliget Tablets: Improving Glycemic Control for Type 2 Diabetes

Zoliget is a blood glucose lowering medication designed to help manage type 2 diabetes when used in conjunction with diet and exercise. It combines pioglitazone and glimepiride to provide additional glycemic control for patients who are already being treated with pioglitazone or glimepiride but need further management of their blood sugar levels.

Indications:

• Adjunct to Diet and Exercise: Zoliget is indicated for patients with type 2 diabetes who require improved glycemic control.
• Combination Therapy: It is specifically designed for patients who are already on a combination of pioglitazone and a sulfonylurea, or those who have initially responded to pioglitazone but need additional control.

Dosage:

• Initial Dose: For patients currently on pioglitazone monotherapy or glimepiride monotherapy, the initial dose is 15 mg/2 mg once daily.
• Maximum Daily Dose: The maximum daily dose is 45 mg/8 mg.
• Switching Therapy: For patients switching from separate tablets of pioglitazone and glimepiride, the initial dose is also 15 mg/2 mg once daily.

Administration:

Take with Food: Zoliget should be taken with the first main meal of the day.

Storage:

• Temperature: Store at temperatures not exceeding 30°C.
• Protection: Protect from light and moisture.

Ingredients:

• Pioglitazone: An active ingredient that helps improve insulin sensitivity.
• Glimepiride: A sulfonylurea that stimulates insulin release from the pancreas.

By using Zoliget as part of your treatment plan, you can better manage your blood sugar levels and improve overall glycemic control. Always consult with your healthcare provider before starting any new medication regimen.